Neumora Therapeutics, Inc.
NMRA
$2.28
$0.052.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 171.53M | 217.59M | 249.35M | 307.58M | 341.31M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.56M | 5.32M | 4.30M | 5.26M | 6.09M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.21M | 1.21M | 1.21M |
| Total Current Assets | 177.08M | 222.91M | 254.87M | 314.06M | 348.61M |
|
|
|||||
| Total Current Assets | 177.08M | 222.91M | 254.87M | 314.06M | 348.61M |
| Net Property, Plant & Equipment | 554.00K | 618.00K | 1.88M | 2.92M | 3.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 197.00K | 298.00K | -- | -- | -- |
| Total Assets | 177.83M | 223.83M | 256.75M | 316.97M | 352.54M |
|
|
|||||
| Total Accounts Payable | 549.00K | 644.00K | 1.05M | 3.31M | 6.11M |
| Total Accrued Expenses | 24.98M | 20.25M | 26.27M | 24.59M | 22.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 256.00K | 171.00K | 938.00K | 1.85M | 2.75M |
| Total Finance Division Other Current Liabilities | 55.00K | 88.00K | 122.00K | 133.00K | 133.00K |
| Total Other Current Liabilities | 55.00K | 88.00K | 122.00K | 133.00K | 133.00K |
| Total Current Liabilities | 25.84M | 21.16M | 28.38M | 29.89M | 31.74M |
|
|
|||||
| Total Current Liabilities | 25.84M | 21.16M | 28.38M | 29.89M | 31.74M |
| Long-Term Debt | 19.56M | 19.45M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 267.00K | 339.00K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 22.00K | 55.00K |
| Total Liabilities | 45.67M | 40.95M | 28.38M | 29.91M | 31.80M |
|
|
|||||
| Common Stock & APIC | 1.26B | 1.25B | 1.24B | 1.23B | 1.21B |
| Retained Earnings | -1.12B | -1.07B | -1.02B | -947.22M | -888.40M |
| Treasury Stock & Other | 9.00K | -15.00K | -3.00K | 62.00K | 105.00K |
| Total Common Equity | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M |
|
|
|||||